In this study, Zhou et al. characterize the molecular, behavioral, and physiological consequences of a novel loss-of-function G118E mutation in the methyl-CpG binding protein MECP2, identified in a patient with Rett syndrome. G118E diminished MECP2 protein levels and independently accelerated its nuclear mobility, altogether limiting MECP2's functional interaction with chromatin in neurons.